Study to Evaluate the Safety and Effectiveness of | Clinical Research Studies Listing

Recruiting

18 years - 65 years

All

135 participants needed

1 Location

Brief description of study

The purpose of this research study is to learn about the safety and effectiveness of the study drug called pitolisant when compared with placebo (a tablet that does not contain any study drug) in treating some of the symptoms of Myotonic Dystrophy Type 1, such as excessive daytime sleepiness.

Detailed description of study

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Daytime Sleepiness, Myotonic Dystrophy Type 1
Age: 18 years - 65 years
Gender: All

Ages 18 to 65 years. Confirmed diagnosis of Myotonic Dystrophy Type 1

Updated on 04 Aug 2024. Study ID: 849131

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

View email

Phone

View phone

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Please provide your preferred way of contact

Race

Select race of your choice

Ethnicity

Select ethinicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.